Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker-Reference-Cited by-同舟云学术

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker

Published:2018-08-31 Issue:68 Volume:9 Page:32984-32996
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Martinez-Bosch Neus¹,Barranco Luis E.¹²,Orozco Carlos A.¹,Moreno Mireia¹,Visa Laura³,Iglesias Mar⁴,Oldfield Lucy⁵,Neoptolemos John P.⁶,Greenhalf William⁵,Earl Julie⁷,Carrato Alfredo⁷,Costello Eithne⁵,Navarro Pilar¹⁸

Affiliation:

1. Cancer Research Program, IMIM, Hospital del Mar Medical Research Institute, Unidad Asociade CSIC, Barcelona, Spain

2. Department of Gastroenterology, Universidad Autonoma de Barcelona, Hospital del Mar, Barcelona, Spain

3. Department of Medical Oncology, Hospital del Mar, Barcelona, Spain

4. Department of Pathology, Universidad Autonoma de Barcelona, Hospital del Mar, CIBERONC, Barcelona, Spain

5. Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK

6. Department of General Surgery, University of Heidelberg, Heidelberg, Germany

7. Department of Medical Oncology, Ramon y Cajal University Hospital, CIBERONC, IRYCIS, Alcala University, Madrid, Spain

8. Institute of Biomedical Research of Barcelona (IIBB-CSIC), Barcelona, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up;Hepatobiliary Surgery and Nutrition;2024-02

2. Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2023-12-18

3. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities;International Journal of Molecular Sciences;2023-10-24

4. Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis;Aging;2023-07-11

5. S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia;BMC Cancer;2023-06-06